dc.contributorUniv Bonn
dc.contributorUniv Marburg
dc.contributorAvastin Data Base Bonn
dc.contributorTriemli Hosp
dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.contributorAsklepios Clin
dc.contributorEye Clin
dc.creatorMeyer, Carsten H.
dc.creatorMichels, Stephan
dc.creatorRodrigues, Eduardo B. [UNIFESP]
dc.creatorHager, Annette
dc.creatorMennel, Stefan
dc.creatorSchmidt, Joerg C.
dc.creatorHelb, Hans-Martin
dc.creatorFarah, Michel Eid [UNIFESP]
dc.date.accessioned2016-01-24T14:06:06Z
dc.date.accessioned2023-09-04T18:22:43Z
dc.date.available2016-01-24T14:06:06Z
dc.date.available2023-09-04T18:22:43Z
dc.date.created2016-01-24T14:06:06Z
dc.date.issued2011-02-01
dc.identifierActa Ophthalmologica. Malden: Wiley-Blackwell Publishing, Inc, v. 89, n. 1, p. 70-75, 2011.
dc.identifier1755-375X
dc.identifierhttp://repositorio.unifesp.br/handle/11600/33393
dc.identifier10.1111/j.1755-3768.2010.02064.x
dc.identifierWOS:000286628100039
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8613869
dc.description.abstractPurpose: To determine the incidence of rhegmatogenous retinal detachments (RD) after intravitreal injection in six high-volume centres.Methods: A consecutive, interventional, multicenter case series measured the incidence of RD in patients receiving intravitreal anti-VEGF. A total of 35 942 intravitreal anti-VEGF injections (the number of the injections determined by review of injection log books over a 3 year period) were performed under sterile conditions with the patient in a supine position. Injections were given 3.5-4.0 mm behind the limbus in a tunnelled fashion.Results: During 36 consecutive months, five RD were reported, between 2 and 6 days after the injection. of the affected eyes, four were myopic) 1.75 to) -5.5 dpt. the incidence rate of rhegmatogenous RD was 0.013% (5/35 942) per injection.Conclusions: the incidence of RD in our community setting was very low (1 per 7188 injections). All RD occurred during the early postoperative period. the risks of RD can be minimized by a careful injection technique.
dc.languageeng
dc.publisherWiley-Blackwell
dc.relationActa Ophthalmologica
dc.rightshttp://olabout.wiley.com/WileyCDA/Section/id-406071.html
dc.rightsAcesso aberto
dc.subjectadverse events
dc.subjectiatrogenic damage
dc.subjectintravitreal injection
dc.subjectneedle
dc.subjectora serrata
dc.subjectrhegmatogenous retinal detachments
dc.titleIncidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections
dc.typeArtigo


Este ítem pertenece a la siguiente institución